CASP8AP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.174100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.883600E-01
Normal-vs-Stage2
5.327500E-02
Normal-vs-Stage3
2.196000E-01
Normal-vs-Stage4
9.905200E-01
Stage1-vs-Stage2
3.864400E-01
Stage1-vs-Stage3
1.004980E-01
Stage1-vs-Stage4
4.143800E-01
Stage2-vs-Stage3
1.156160E-01
Stage2-vs-Stage4
2.415600E-02
Stage3-vs-Stage4
9.520300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.181600E-02
Normal-vs-AfricanAmerican
3.439200E-01
Normal-vs-Asian
7.582300E-02
Caucasian-vs-AfricanAmerican
5.850000E-01
Caucasian-vs-Asian
2.179800E-01
AfricanAmerican-vs-Asian
2.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.963900E-02
Normal-vs-Female
1.206010E-01
Male-vs-Female
1.903770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.799400E-01
Normal-vs-Age(41-60Yrs)
1.330420E-01
Normal-vs-Age(61-80Yrs)
5.628300E-02
Normal-vs-Age(81-100Yrs)
1.218410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.718000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.584800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.814400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.544760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.089000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.439000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.450000E-01
Normal-vs-Daily Drinker
2.825600E-01
Normal-vs-Weekly Drinker
9.131600E-02
Normal-vs-Occasional Drinker
1.839760E-01
Normal-vs-Social Drinker
3.697200E-01
Non Drinker-vs-Daily Drinker
3.038400E-01
Non Drinker-vs-Weekly Drinker
8.463200E-01
Non Drinker-vs-Occasional Drinker
3.374400E-01
Non Drinker-vs-Social Drinker
1.100370E-01
Daily Drinker-vs-Weekly Drinker
2.989800E-01
Daily Drinker-vs-Occasional Drinker
8.421800E-02
Daily Drinker-vs-Social Drinker
2.621500E-02
Weekly Drinker-vs-Occasional Drinker
5.437000E-01
Weekly Drinker-vs-Social Drinker
2.610200E-01
Occasional Drinker-vs-Social Drinker
5.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.356400E-01
Normal-vs-Grade 2
1.571360E-01
Normal-vs-Grade 3
1.183980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.590800E-01
Grade 1-vs-Grade 3
2.024600E-01
Grade 1-vs-Grade 4
2.356400E-01
Grade 2-vs-Grade 3
3.075000E-01
Grade 2-vs-Grade 4
1.571360E-01
Grade 3-vs-Grade 4
1.183980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.642000E-02
Normal-vs-NonDiabetic
3.643000E-01
Diabetic-vs-NonDiabetic
9.241800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.056400E-01
Normal-vs-NoPancreatitis
3.770600E-01
Pancreatitis-vs-NoPancreatitis
3.221000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.330960E-01
Normal-vs-N1
5.412400E-02
N0-vs-N1
9.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.640200E-01
Normal-vs-TP53-NonMutant
2.612800E-01
TP53-Mutant-vs-TP53-NonMutant
4.652000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
